Increasing prevalence of digestion disorders, common flu, and cold is driving grPosted by rohan on August 23rd, 2018 South Korea over-the-counter (OTC) drugs market is predicted at USD 4.70 billion in 2018 and is anticipated to reach USD 6.63 billion by using 2023, developing at a CAGR of 7.11%. Over-the-counter (OTC) drugs also called as non-prescription drugs are drug treatments that don't require the prescription from healthcare experts for selling it to customers. The clients can follow the instructions mentioned on label and those drugs are safe to apply. Those drugs are available at pharmacies, supermarkets, popular stores, and fuel stations throughout numerous international locations. Request Report Sample: https://www.marketdataforecast.com/market-reports/south-korea-over-the-counter-drugs-market-802/request-sample Escalating awareness on treatments is to thrive the market growth Factors affecting market growth:
Get your customized report:https://www.marketdataforecast.com/market-reports/south-korea-over-the-counter-drugs-market-802/customize-report Pharmacies hold the largest segment of the market Market Segmentation The Global over-the-counter (OTC) drugs market is segmented on the basis of Product Type
By Formulation Type
Distribution Channels
As stated in advance, most of the OTC drugs in South Korea are distributed through Pharmacies. But with the efforts of authorities to ease the regulations, income by supermarkets and convenience stores are expected to choose up within the coming few years. Key players: Some of the main companies of the market include GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi, Takeda Pharmaceuticals, Boehringer Ingelheim, Yuhan Corporation, Hanmi Pharmaceuticals, Dong Wha Pharmaceuticals. Contact Info: Phone: +1-888-702-9626 Like it? Share it!More by this author |